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13C metabolic flux analysis (13C MFA) is an important systems biology technique that 
has been used to investigate microbial metabolism for decades. The heterotrimer Snf1 
kinase complex plays a key role in the preference Saccharomyces cerevisiae exhibits 
for glucose over galactose, a phenomenon known as glucose repression or carbon 
catabolite repression. The SIP1 gene, encoding a part of this complex, has received 
little attention, presumably, because its knockout lacks a growth phenotype. We present 
a fluxomic investigation of the relative effects of the presence of galactose in classi-
cally glucose-repressing media and/or knockout of SIP1 using a multi-scale variant of 
13C MFA known as 2-Scale 13C metabolic flux analysis (2S-13C MFA). In this study, all 
strains have the galactose metabolism deactivated (gal1Δ background) so as to be 
able to separate the metabolic effects purely related to glucose repression from those 
arising from galactose metabolism. The resulting flux profiles reveal that the presence 
of galactose in classically glucose-repressing conditions, for a CEN.PK113-7D gal1Δ 
background, results in a substantial decrease in pentose phosphate pathway (PPP) flux 
and increased flow from cytosolic pyruvate and malate through the mitochondria toward 
cytosolic branched-chain amino acid biosynthesis. These fluxomic redistributions are 
accompanied by a higher maximum specific growth rate, both seemingly in violation of 
glucose repression. Deletion of SIP1 in the CEN.PK113-7D gal1Δ cells grown in mixed 
glucose/galactose medium results in a further increase. Knockout of this gene in cells 
grown in glucose-only medium results in no change in growth rate and a corresponding 
decrease in glucose and ethanol exchange fluxes and flux through pathways involved in 
aspartate/threonine biosynthesis. Glucose repression appears to be violated at a 1/10 
ratio of galactose-to-glucose. Based on the scientific literature, we may have conducted 
our experiments near a critical sugar ratio that is known to allow galactose to enter the 
cell. Additionally, we report a number of fluxomic changes associated with these growth 
rate increases and unexpected flux profile redistributions resulting from deletion of SIP1 
in glucose-only medium.
Keywords: 13c metabolic flux analysis, genome-scale models, glucose repression, yeast, metabolomics
FigUre 1 | simplified depiction of snf1 kinase complex in and its regulatory interactions. The Snf1 kinase complex is a heterotrimer consisting of a 
catalytic α-subunit Snf1, regulatory γ-subunit Snf4, and one of three β-subunits Sip1, Sip2, or Gal83. Under glucose-repressing conditions, these components are 
found unassembled in the cytosol and, conversely, upon glucose depletion they assemble into all three isoforms of the complex (comprising either Sip1, Sip2, or 
Gal83). The isoform bound to Gal83 localizes in the nucleus and activates genes responsible for alternate carbon source utilization, the isoform bound to Sip2 
remains in the cytosol, and the isoform bound to Sip1 is sequestered in the vacuole. Reconstructed and modified from Zaman et al. (2008).
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1. inTrODUcTiOn
In the presence of glucose, Saccharomyces cerevisiae represses con-
sumption of other carbon sources. This phenomenon, known as 
glucose repression, involves the repression of genes and pathways 
involved in respiration (e.g., TCA cycle, etc.), the use of alternative 
fermentable (e.g., sucrose and galactose) and non-fermentable 
(e.g., ethanol and acetate) carbon sources, and gluconeogenesis 
(Zaman et  al., 2008; Kayikci, 2015). A better understanding of 
glucose repression could improve mixed-carbon source fermen-
tation using biomass feedstocks (Apel et  al., 2016) and, hence, 
production of biofuels and other renewable bioproducts (Nielsen 
et al., 2013).
The Sip1 protein is a component of the Snf1 (sucrose non-
fermenting 1) kinase complex, which is central to glucose 
repression in S. cerevisiae. The Snf1 kinase complex is the yeast 
analog of AMPK (adenosine monophosphate-activated protein 
kinase), a well studied and highly conserved eukaryotic regulator 
of cellular uptake of glucose, energy homeostasis, beta-oxidation 
of fatty acids, etc. (Winder and Hardie, 1999). As depicted in 
Figure 1, the Snf1 kinase complex is a heterotrimer consisting of 
a catalytic α-subunit Snf1, regulatory γ-subunit Snf4, and one of 
three β-subunits Sip1, Sip2, or Gal83. Under glucose-repressing 
conditions, these components are found unassembled in the 
cytosol and, conversely, upon glucose depletion they assemble 
into all three isoforms of the complex (containing either Sip1, 
Sip2, or Gal83). The isoform bound to Gal83 localizes in the 
nucleus and activates genes responsible for alternate carbon 
source utilization, the isoform bound to Sip2 remains in the 
cytosol, and the isoform bound to Sip1 is sequestered in the 
vacuole (Zaman et al., 2008).
Little is known about the role of Sip1 under these conditions 
due to a reported lack of phenotypic difference in growth between 
wild type and sip1Δ mutants (Breslow et al., 2008; Zaman et al., 
2008; Zhang et al., 2010).
One thing that is known about Sip1 is that it is a negative 
regulator of the galactose utilization system (Mylin et al., 1994), 
as depicted in Figure 2. Deletion of SIP1 in yeast is known to 
increase expression of GAL2, the galactose transporter gene, by 
2- to 3-fold in glucose-repressing conditions. However CEN.
PK113-7D is known to be gal2− (Hansche et  al., 1978). The 
presence of galactose in the cell activates Gal3 which, in turn, 
represses Gal80. Gal80 represses Gal4 a known regulator for 
many genes, including those involved in alternate carbon source 
FigUre 2 | Depiction of GAL gene interactions with sip1 in a GAL1 knockout background. Deletion of SIP1 is known to increase expression of GAL2, the 
galactose transporter gene, by 2- to 3-fold in glucose-repressing conditions. However, CEN.PK 113-7D is known to be gal2−. The presence of galactose in the cell 
activates Gal3 which, in turn, represses Gal80. Gal80 represses Gal4 so the full effect is that the deletion of Sip1 derepresses galactose regulation in the cell and, in 
the end, activates Gal4, a known regulator for many genes, including those involved in alternate carbon source utilization, RNA polymerase III, etc. Green arrows 
indicate activation and red blunt arrows indicate repression.
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utilization, RNA polymerase III, etc. (Ideker et al., 2001; Zhang 
et al., 2010).
In spite of a lack of reported phenotypic difference upon 
knockout of SIP1, in one of our previous studies (Shymansky, 
2011), we noticed an increase in specific growth rate upon dele-
tion of this gene in a medium containing both galactose and 
glucose (though in a different background than reported here: 
S288c ura3Δ gal1Δ). We were curious about what shifts in the 
cell’s metabolic flux profile might be associated with this increase 
in growth rate. Additionally, we wanted to know how the pres-
ence of galactose interacted with this genetic perturbation from 
a fluxomic perspective.
In this study, we will look into the metabolic effects created 
by the deletion of SIP1 by measuring and comparing internal 
metabolic fluxes, key determinants of microbial physiology. All 
strains have galactose metabolism deactivated, so as to be able 
to distinguish glucose repression effects from the impact of 
galactose metabolism on overall metabolism. Internal metabolic 
fluxes represent the biomass-normalized activity of metabolic 
reactions in an organism per hour (Wiechert, 2001; Sauer, 2006). 
The collection of these metabolic fluxes is known as the fluxome 
and maps the flow of material through a cell’s metabolism.
Arguably, the two most popular methods of studying flux 
profiles are Flux Balance Analysis (FBA (Lewis et al., 2012)) and 
13C metabolic flux analysis (13C MFA (Wiechert, 2001; Zamboni, 
2011)). FBA uses comprehensive genome-scale metabolic models 
coupled with experimentally obtained flux bounds and a biologi-
cal objective (e.g., maximization of growth rate, maximization of 
ATP production, etc.) to infer flux profiles. 13C MFA determines 
fluxes by combining flux bounds with experimentally measured 
labeling distributions resulting from 13C tracer experiments. 
Instead of assuming a biological objective, it fits simulated labeling 
distributions to their measured counterparts. However, it tends to 
use a less comprehensive metabolic network (García Martín et al., 
2015). 13C MFA has been used in S. cerevisiae to study general 
batch growth (Maaheimo et al., 2001; Frick and Wittmann, 2005), 
anaerobic versus aerobic growth (Gombert et  al., 2001; Fiaux 
et al., 2003), varying environmental conditions (Blank and Sauer, 
2004), and different gene deletion mutants (Gombert et al., 2001; 
Blank et al., 2005; Moxley et al., 2009), among others.
A recently published method (García Martín et  al., 2015), 
2-scale 13C MFA (2S-13C MFA), combines the strengths of both 
FBA and 13C MFA: comprehensive genome-scale models con-
strained by 13C labeling data without the recourse to a biological 
objective. This approach models metabolism at two different scales 
of resolution: the lower scale of resolution constrains fluxes using 
only stoichiometry for the whole genome-scale model, while a 
higher resolution scale uses carbon labeling patterns on top of 
stoichiometry to constrain fluxes for a limited core set of reac-
tions anticipated to carry most of the flux. A critical assumption 
is that most core reaction’s metabolites are not heavily affected 
by peripheral metabolism, an assumption that is routinely used 
in 13C MFA and can describe experimental data satisfactorily 
(Antoniewicz et al., 2007; Schaub et al., 2008; Moxley et al., 2009). 
This assumption is tested through a External Labeling Variability 
Analysis (ELVA), and the core set of reactions can be changed 
as needed to guarantee self-consistency. The results for the core 
reactions for 2S-13C MFA are equivalent to those for 13C MFA, 
but 2S-13C MFA extrapolates the constraints induced by the 13C 
labeling data to a genome-scale model. The advantage of 2S-13C 
TaBle 3 | Primers used to Pcr verify specific gene deletions.
Knocked out gene F-primer r-primer
GAL1 TTATTTCTGGGGTAAT TCCCTGTGTTTCAA
TAATCAGCGAAG AGTTTGTGG
SIP1 GCACTTCTTTTTTTGC CGTTCTAGGAGCCA
GTGTGG TAGGAATC
TaBle 2 | Deleted genes and corresponding templates and forward/
reverse primers used to construct knockout cassettes.
Knocked 
out gene
Template F-primer r-primer
GAL1 pUG6 AAAAATTGTTAATAT 
ACCTCTAACGTCA 
AGGAGAAAAAagc 
tgaagcttcgtacgc
GTAGAAAAAAATG 
AGAAGTTGTTCTGA 
ACAAAGTAA 
AAAAAAGAAGTATACc 
ataggccactagtggatctg
SIP1 pUG6 CTGACATCTTGGAAAG 
TTGAACTGTCATATTA 
TATAGTTGTTGCAGCC 
GCCagctgaagcttcgtacgc
AGAAAAAAATTGAA 
TTAATAGAGTTCGTG 
AGAATCATTGCGAATT 
GAGAaggccactag 
tggatctg
Uppercase indicates homologous flanking regions and lowercase designates regions 
binding to pUG6 plasmid.
TaBle 1 | list of strains, their parents, and genotypes.
strain 
name
Parent 
strain
Description ice part iD
CPU CEN.PK113-7D CEN.PK113-7D ura3Δ JBx_026749
CMSY3 CPU CPU SIP1::loxP-kanMX-loxP JBx_026263
CMSY4 CMSY3 CPU sip1Δ JBx_026264
CMSY5 CPU CPU GAL1::loxP-kanMX-loxP JBx_026208
CMSY7 CMSY5 CPU gal1Δ JBx_026210
CMSY6 CMSY4 CPU sip1Δ GAL1::loxP-kanMX-loxP JBx_026209
CMSY8 CMSY6 CPU sip1Δ gal1Δ JBx_026211
base CMSY7 CPU gal1Δ [pRS416] JBx_026749
sip1Δ CMSY8 CPU sip1Δ gal1Δ [pRS416] JBx_026750
Details are available in the public instance of the JBEI public registry (Ham et al., 2012) 
(https://public-registry.jbei.org).
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MFA versus using full genome-scale carbon labeling tracking 
is that it is a general approach that can be used even if carbon 
transitions are not available for the full genome-scale model [as 
is the case for S. cerevisiae (Gopalakrishnan and Maranas, 2015)]. 
Furthermore, it can easily leverage information from previous 13C 
MFA studies (Ghosh et al., 2016).
In this study, we performed an exploratory analysis, via 2S-13C 
MFA, of a set of GAL1− strains with (base strain) and without (sip1Δ 
knockout) an intact SIP1 gene, similar to those from our previous 
work (Shymansky, 2011), but in the more industrially relevant 
CEN.PK113-7D background. We characterized growth and flux 
profiles for both strains in both glucose-only and mixed glucose/
galactose medium and used the detailed information provided by 
flux profiles to gain insight into the ensuing metabolic changes. 
The point of this study was to investigate in detail the surprising 
effect of a change in growth when adding galactose during glucose 
repression conditions, when galactose should have been ignored 
by the cell. We use flux analysis because fluxes describe how mass 
and energy are distributed in cell metabolism and growth rate 
changes are modeled in genome-scale models as changes in flux 
for biomass reactions (i.e., reactions that codify all metabolites 
needed for creating a new cell). 2S-13C MFA is unique because 
it measures fluxes for genome-scale models in an accurate and 
comprehensive manner, being able to map all reactions encoded 
in the genome. In this way, we can study in detail how metabolism 
has been affected by a perturbation that should not have affected it.
2. MaTerials anD MeThODs
2.1. Media and culturing conditions
Media used in this study, along with their component concen-
trations, are listed in Table S1 in Supplementary Material. For 
both genetic manipulations and growth and tracer experiments, 
all strains were grown in non-baffled shake flasks at 30°C at 
200  rpm in either minimal glucose medium (Min), minimal 
glucose medium with galactose (Min +  Gal), YPD, or Sc-Ura. 
All strains were stored in 20% glycerol stocks at −80°C. Labeled 
media used 80% 1-13C glucose and 20% U-13C glucose at the same 
total concentration of 2% glucose. Exponential-phase cells were 
obtained by streaking from −80°C glycerol stocks on YPD plates, 
incubating 5-mL YPD cultures overnight, inoculating into 40 mL 
of unlabeled media of the final desired composition, and grown 
until exponential phase (usually 0.6–0.9 OD600).
2.2. strain construction
Prototrophic base (base) and mutant (sip1Δ) S. cerevisiae strains 
were constructed in a haploid CEN.PK113-7D (MATa URA3 HIS3, 
LEU2 TRP1 MAL2-8c SUC2) (Entian and Kötter, 2007) background 
containing a URA3 knockout. All strains used in this study are 
listed in Table 1 with their strain designations, parent strain, geno-
type descriptions, and Inventory of Composable Elements (ICE) 
reference numbers (Ham et al., 2012) (https://public-registry.jbei.
org). All knockouts were constructed via a near-markerless loxP/
Cre recombinase strategy (Güldener et al., 1996) and PCR verified. 
Briefly, each knockout cassette was amplified from a loxP-kanMX-
loxP plasmid, pUG6 (Güldener et  al., 1996), using the primers 
listed in Table 2, transformed into yeast using a heat shock method 
(Agatep et al., 1998), selected on YPD + G418 (geneticin) plates, 
and PCR verified using primers listed in Table 3. In order to loop out 
the kanMX marker, a Cre recombinase plasmid was transformed 
in the resulting kanMX cassette integrants and plated on selective 
medium. The selective plate varied depending on the knockout. 
For knockout of SIP1, the Cre recombinase promoter was Gal1p 
[pSH47 (Güldener et al., 1996)] and selection occurred on pSH47 
plates. A different plasmid was necessary for knockout of GAL1, 
since the strain could not grow on galactose. We opted for expres-
sion of the Cre recombinase under a constitutive TEF1 promoter. 
This new plasmid, pCMS1, was constructed via yeast cloning 
using SacI and XbaI digested pSH47, to excise Gal1p, and Tef1p 
amplified with regions homologous to the cut ends and subsequent 
selection on Sc-Ura plates. All loop-outs were PCR verified using 
the same verification primers in Table 3 and pCMS1 was sequence 
verified. Cre recombinase plasmids were cured by streaking on 
YPD plates, growing overnight in liquid YPD medium, streaking 
5Shymansky et al. Glucose Repression Flux Study
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to single colonies on YPD plates, simultaneously streaking on YPD 
and Sc-Ura plates, and glycerol storing YPD plate colonies whose 
corresponding Sc-Ura colonies did not grow. Prototrophic final 
base and mutant strains were completed via transformation of a 
URA3 plasmid, pRS416 (Sikorski and Hieter, 1989).
2.3. growth characterization and Tracer 
experiments
Cell and extracellular metabolite concentrations were moni-
tored during exponential phase in strain characterization batch 
experiments. These data were necessary to calculate extracellular 
fluxes and specific growth rates used to mathematically constrain 
flux profile inference. Exponentially growing cells, obtained as 
described in the Media and culturing conditions section, were 
used to inoculate, in quadruplicate, the final 40-mL shake flask 
cultures to achieve exponential growth the following morning. 
Optical density was monitored at 600 nm via UV–VIS, and 200 µL 
samples were spin-filtered and kept at −20°C for subsequent 
HPLC analysis.
Exponentially growing cells (obtained as described above) were 
used to inoculate 40 mL labeled shake flask cultures in quadrupli-
cate and monitored via UV–VIS. To prevent changes in intracellular 
metabolite labeling patterns, 1 mL mid-log (~0.75 OD600) samples 
were taken, spun down (1  min, max speed, 4°C), immediately 
quenched with 300 µL ice-cold methanol, and kept at −80°C.
2.4. labeled Biomass sample Processing
Labeling distributions were obtained from processed labeled 
biomass samples for intracellular 3-phospho-d-glycerate (3 pg), 
alanine (Ala), arginine (Arg), asparagine (Asp), glutamine (Gln), 
glutamate (Glu), isoleucine (Ile), leucine (Leu), lysine (Lys), 
phenylalanine (Phe), threonine (Thr), tyrosine (Tyr), valine (Val), 
citrate (cit_m), fructose 1,6-bisphosphate (fdp), and succinate 
(succ_m). Succinate and citrate were assumed to be mitochon-
drial, while the rest are assumed to be cytosolic as has been done 
in previous studies (Moxley et al., 2009). The closeness of fit of 
these data with corresponding simulated values provided a meas-
ure of the quality of inferred flux distributions. Labeled biomass 
samples were mixed with 300 µL ice-cold chloroform and 150 µL 
ice-cold water, spun down, bead-beated with 500 µL acid-washed 
beads (10 times, 10 s, 1 min on ice between sonication bursts) in 
1.7 mL screw cap tubes, the bottom of the tube was punctured 
with a needle, and the beads were separated from the solution 
by spinning (1 min, 1,000 g, 4°C) into a 2-mL collection tube. 
The aqueous layer was filtered (3 k MW cut-off (Amicon), 1.5 h, 
13,000 g, 4°C), mixed with 1 mL ice-cold H2O, and snap frozen 
in liquid nitrogen. Three holes were punched in the tube cap, and 
the samples were lyophilized for 24 h. Lyophilized samples were 
resuspended in 40 µL 50/50 MeOH/H2O, and stored at −80°C. 
Samples were analyzed to obtain intracellular amino acid and 
non-amino acid labeling data via LC-MS as previously described 
(Bokinsky et al., 2013; Weaver et al., 2015).
2.5. extracellular concentration 
Determination
Extracellular concentrations for glucose, galactose, ethanol, 
glycerol, succinate, lactate, acetate, and formate were measured 
via HPLC. These concentrations, along with corresponding 
culture specific growth rates, were necessary to calculate extra-
cellular fluxes. The 4 mM H2SO4 eluent flowed through a 1200 
Series HPLC (Agilent Technologies, CA) outfitted with UV and 
refraction index detectors and an Organic Acid Analysis Column 
(Aminex HPX-87H Ion Exclusion Column, 300  mm 7.8  mm, 
50°C, Cat# 125-0140 Bio-Rad, CA, USA) at a rate of 0.6 mL/min. 
Standards were used to identify metabolite retention times and 
sample concentrations.
2.6. extracellular Flux and intracellular 
labeling input calculations
Extracellular fluxes and specific growth rates were derived from 
extracellular concentration and optical density time curves. Their 
means and standard deviations were used to constrain exchange 
fluxes for consumed and excreted metabolites and biomass fluxes 
during flux profile inference. Flask-specific maximum specific 
growth rates were determined from the slope of lnOD versus 
time data in manually determined linear ranges. The same time 
points were used with corresponding concentration data to 
calculate extracellular fluxes. The extracellular flux of metabolite 
p, νp, is give by equation (1). Mp is the corresponding molecular 
weight of metabolite p, α is the conversion factor between OD600 
and cell mass concentration in grams of dry cell weight per liter 
(gDcW/L), and dCp dOD/  is the slope of the concentration of 
metabolite p versus OD600. The value of α was taken to be 0.7742 
based on multiple in-house experiments (data not shown). The 
average plus and minus the corresponding standard deviation 
was used to constrain all extracellular fluxes and specific growth 
rates.
 
ν
µ
αp pM
dCp
d
=1 000, ,
OD  
(1)
Units are in mmol/gDcW/hr (hence the 1,000 factor).
2.7. Flux Profile inference via 2s-13c MFa
Flux profiles were inferred from growth and tracer experiment 
data using 2-scale-13C metabolic flux analysis (2S-13C MFA) 
(García Martín et  al., 2015). These fluxes, along with specific 
growth rates and extracellular fluxes were used to characterize 
the relative effects of the presence of galactose and/or knockout 
of SIP1. 2S-13C MFA was chosen over 13C MFA for its ability to 
describe metabolism more comprehensively through genome-
scale models, iMM904 (Mo et al., 2009) in this case. The means 
and standard deviations for strain/condition-specific extracel-
lular fluxes, intracellular metabolite LC-MS fractional labeling 
distributions, specific growth rates, and feed glucose labeling 
were used as inputs for the code included as Supplementary 
Material. The carbon transitions differed for each strain/
condition pair as demanded by the ELVA requirements [see 
Figure 4 and supp. Fig 22 in García Martín et  al. (2015)]. 
Starting from a base core reaction network, carbon transition 
information was added to reactions (i.e., the reaction was 
added to the core network) with the largest flux from non-core 
metabolism to core metabolism. This was performed iteratively 
until computational errors in the ELVA plot were minimal. 
FigUre 3 | Box-and-whisker plot of maximum specific growth rates for four biological replicates (n = 4) per strain/condition pair. Middle box line 
represents median and edges represent first and third quartiles. Whiskers represent range of data. All data points are displayed. Knockout of SIP1 had no effect on 
growth in glucose-repressing minimal medium. Surprisingly, under glucose-repressing conditions, the presence of galactose in the medium had an effect on growth 
rate, one that was intensified by the SIP1 knockout.
TaBle 4 | extracellular fluxes, νmetabolite, or maximum specific growth rate, 
μ, means plus or minus the standard deviation for all strain/condition 
pairs.
νmetabolite 
or μ
U s Ug sg
μ 0.375 ± 0.007 0.372 ± 0.009 0.407 ± 0.004 0.440 ± 0.003
Glucose 65.71 ± 14.50 36.60 ± 3.47 32.33 ± 4.72 64.06 ± 10.26
Acetate 0.73 ± 0.08 0.62 ± 0.11 1.12 ± 0.09 1.71 ± 0.22
Ethanol 20.62 ± 1.84 5.87 ± 3.52 15.96 ± 2.30 20.56 ± 2.84
Formate −0.016 ± 0.03 n.d. n.d. n.d.
Glycerol 1.49 ± 0.10 1.30 ± 0.21 1.71 ± 0.32 3.00 ± 0.61
Succinate n.d. n.d. n.d. n.d.
Lactate n.d. n.d. n.d. n.d.
Fluxes are in mmol/gDcW/h and growth rates are in 1/h. Strain/condition pair 
designations U, S, UG, and SG refer to base in 2% glucose, sip1Δ in 2% glucose, 
base in 2% glucose + 0.2% galactose, and sip1Δ in 2% glucose + 0.2% galactose, 
respectively.
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This test guaranteed that labeling from outside the core model 
[e.g., labeling from CO2 and formate (Gopalakrishnan and 
Maranas, 2015)] had a minimal impact in the measured labeling 
patterns. A final 13C Flux Variability Analysis (13C FVA) was used 
to find the maximum and minimum values of each flux com-
patibles with the experimental data [see (García Martín et al., 
2015) for more details]. Our code uses the CONOPT Solver in a 
GAMS framework to perform the 13C MFA step using 30 initial 
flux starting points.
Confidence intervals and goodness-of-fit were calculated as 
in García Martín et al. (2015). Briefly, the usual 13C MFA good-
ness-of-fit estimates based on the chi square distribution, such as 
those proposed by Antoniewicz et al. (2006), are not applicable to 
2S-13C MFA using genome-scale models [see page 24 in García 
Martín et al. (2015)]. This problem was surmounted by incorpo-
rating the goodness-of-fit considerations in the confidence inter-
vals: good fits produce narrow flux confidence intervals (good 
flux resolution) and bad fits produce large confidence intervals 
(bad flux resolution). These confidence intervals are calculated 
by finding the maximum and minimum values of each flux 
compatible with experimental error [page 26 in García Martín 
et  al. (2015)]. The experimental error for each m in the Mass 
Distribution Vector (MDV) was the maximum of the instrument 
error and the difference of the best fit computational labeling 
with the experimental labeling [equation (23) in García Martín 
et al. (2015)]. Hence a bad fit provides a large experimental error 
and begets large flux confidence intervals and less flux resolution, 
and a good fit provides narrower confidence intervals and better 
flux resolution.
3. resUlTs
3.1. growth rates
The presence of galactose in the medium increased the maximum 
specific growth rate for both base and sip1Δ mutant strains. 
Additionally, the deletion of SIP1 only resulted in a growth rate 
increase when galactose was present in the medium. Average 
maximum specific growth rates for the four strain/condition 
combinations are presented in Table 4 and a corresponding box-
and-whisker plot is presented in Figure 3. An ~8.5% increase was 
observed when the base strain was grown in medium with sup-
plemented galactose instead of glucose-only medium (base in 2% 
glucose versus base in 2% glucose + 0.2% galactose). Similarly, 
the sip1Δ mutant grew ~18% faster in galactose-supplemented 
medium relative to that without (sip1Δ in 2% glucose versus 
sip1Δ in 2% glucose + 0.2% galactose). The sip1Δ mutant grew 
~8% faster than the base strain in mixed glucose/galactose 
medium (base in 2% glucose + 0.2% galactose versus sip1Δ 2% 
glucose + 0.2% galactose). Consistent with the literature (Breslow 
et al., 2008; Zhang et al., 2010), no change in maximum specific 
growth rate was observed between the base and sip1Δ mutant 
strains in glucose-only medium (base in 2% glucose versus sip1Δ 
in 2% glucose).
FigUre 4 | Detailed fits between simulated (blue bars) and measured (red bars) intracellular metabolite labeling distributions for base in 2% glucose 
(U) (other strain/conditions can be found in supplementary Material). The correspondence between simulated and measured labeling distributions validates 
the model. The green box corresponds to a metabolite that was not included in calculating the fluxes (i.e., the fit): its computational labeling distribution values were 
derived from the fluxes obtained from all the other metabolites, further validating the model. Confidence intervals and goodness-of-fit considerations are addressed 
in Materials and Methods (section 2.7).
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3.2. extracellular Fluxes
Neither the presence of galactose nor knockout of SIP1 resulted 
in any clear pattern in the extracellular fluxes. The means and 
standard deviations for all monitored extracellular metabolites for 
all strain/condition pairs can be found in Table 4. The extracel-
lular flux input ranges, as the mean plus or minus one standard 
deviation, for strain condition pairs base in 2% glucose, sip1Δ in 
2% glucose, base in 2% glucose + 0.2% galactose, and sip1Δ in 
2% glucose + 0.2% galactose are presented in Table 4. The sip1Δ 
mutant consumed glucose and excreted ethanol at ~44% and 
~72% lower rates, respectively, than the base strain in glucose-
only medium (base in 2% glucose versus sip1Δ in 2% glucose). 
The sip1Δ mutant in glucose/galactose medium relative to the 
parental strain (base in 2% glucose + 0.2% galactose vs sip1Δ in 2% 
glucose + 0.2% galactose) exhibited a ~98% increase in absolute 
glucose flux, a ~70% increase in absolute ethanol flux, and a ~54% 
increase in acetate. Addition of 0.2% galactose to the medium of 
the base strain (base in 2% glucose vs base in 2% glucose + 0.2% 
galactose) resulted in a decrease in absolute glucose flux of ~51% 
and an increase of ~55% for acetate flux. Addition of galactose to 
the medium of the mutant strain (sip1Δ in 2% glucose vs sip1Δ 
in 2% glucose + 0.2% galactose) resulted in a ~75% increase in 
absolute glucose flux, a ~250% increase in ethanol flux, a ~130% 
increase in glycerol flux, and a ~175% increase in acetate flux. 
Lactate, formate, and succinate were not detected in any strain/
condition pair, hence their extracellular fluxes were considered 
zero. All other absolute fluxes were the same for all strain/condi-
tion pairs within error. The presence of galactose in the medium 
of the sip1Δ mutant appeared to restore the ethanol flux to its 
value before the gene knockout (sip1Δ in 2% glucose versus sip1Δ 
in 2% glucose + 0.2% galactose), within error.
In spite of this lack of clear patterns, we will see below that the 
addition of 13C labeling information in the context of the genome-
scale model results in noticeable patterns for the intracellular 
fluxes.
3.3. Fits and elVa Plots
Detailed fits between simulated and measured LC-MS data for 
metabolites 3-phospho-d-glycerate (3  pg), alanine (Ala), argi-
nine (Arg), asparagine (Asp), glutamine (Gln), glutamate (Glu), 
isoleucine (Ile), leucine (Leu), lysine (Lys), phenylalanine (Phe), 
threonine (Thr), tyrosine (Tyr), valine (Val), citrate (cit_m), 
fructose 1,6-bisphosphate (fdp), and succinate (succ_m) are 
displayed in Figure 4 for strain/condition pair base + 2% glucose 
and in Figures S1–S3 in Supplementary Material for sip1Δ in 2% 
glucose, base in 2% glucose + 0.2% galactose, and sip1Δ in 2% 
glucose +  0.2% galactose, respectively. We decided to exclude 
the labeling data for citrate from the fitting to test how well the 
fluxes fit by the other metabolites could predict its labeling. 
Predicted citrate labeling closely matches that measured. The 
ELVA plots (García Martín et  al., 2015), used to confirm that 
reactions external to the core set do not significantly contribute 
to the core labeling, for all strain/condition pairs are presented 
in Figure S4 in Supplementary Material. Strain/condition pair 
sip1Δ in 2% glucose + 0.2% galactose exhibited more variability 
in both its measured and simulated data errors. Also, sip1Δ in 
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2% glucose +  0.2% galactose had a somewhat worse fit. The 
whole flux profiles corresponding to these strain/condition pair 
ELVA plots are displayed in Figures S5–S8 in Supplementary 
Material for base in 2% glucose, sip1Δ in 2% glucose, base in 
2% glucose + 0.2% galactose, and sip1Δ in 2% glucose + 0.2% 
galactose, respectively. All values are normalized to the absolute 
glucose uptake rate. As indicated in the legend in the lower-right 
of the figure, differently colored small arrows indicate the use of 
particular cofactors. Cofactors displayed are NADPH, NADH, 
ATP, GLN-L, AKG-L, NADP, NAD, ADP, GLU-L, ACCOA 
(acetyl-CoA), FOR (formate), CO2, AMP, and CoASH. Arrows 
pointing toward the main black reaction arrow indicate the cofac-
tor is a reactant and vice versa.
3.4. Pentose Phosphate Pathway activity
The presence of galactose appeared to greatly reduce pentose 
phosphate pathway (PPP) activity. The split between glycolysis 
and the PPP for strain/condition pairs base in 2% glucose, 
sip1Δ in 2% glucose, base in 2% glucose + 0.2% galactose, and 
base in 2% glucose + 0.2% galactose are displayed in Figure 5 
and individual flux values and their absolute ranges from the 
ELVA are presented in Table  5. When switching from Min to 
Min + Gal the base strain’s PPP activity reduced by about 94% 
(base in 2% glucose versus base in 2% glucose + 0.2% galactose). 
Analogously, the PPP flux for the SIP1 null mutant decreased a 
similar ~93% when galactose was present in the medium (sip1Δ 
in 2% glucose versus sip1Δ in 2% glucose + 0.2% galactose).
3.5. inactive glyoxylate and Tca cycles
Both the TCA cycle and the glyoxylate shunt, as expected from 
glucose repression, appeared to be almost completely repressed 
across all strain/condition pairs (~1%). This is mostly consistent 
with the 13C MFA literature, which indicates a small amount of 
activity (usually about 1–2% of total glucose consumption flux) 
in glucose-repressing conditions for CEN.PK113-7D (Gombert 
et  al., 2001; Maaheimo et  al., 2001; Blank and Sauer, 2004; 
Blank et  al., 2005). Fluxes surrounding mitochondrial import 
and export for strain/condition pairs base in 2% glucose, sip1Δ  
in 2% glucose, base in 2% glucose + 0.2% galactose, and sip1Δ in 
2% glucose + 0.2% galactose are displayed in Figures S9–S12 in 
Supplementary Material, respectively.
3.6. Mitochondrial import/export and 
Branched-chain amino acid generation
The presence of galactose in the medium for either the base or 
mutant strains, both with galactose metabolism deactivated, 
appears to greatly increase mitochondrial activity (Figures S9–S12 
in Supplementary Material). Neither strain exhibits mitochondrial 
import of malate or pyruvate in glucose-repressing conditions. 
Addition of 0.2% galactose to the medium of both strains (base in 
2% glucose vs base in 2% glucose + 0.2% galactose and sip1Δ in 
2% glucose vs sip1Δ in 2% glucose +  0.2% galactose) resulted 
in a dramatic import of malate. This malate is fed through the 
NADP-dependent malic enzyme to generate mitochondrial pyru-
vate. Similarly, pyruvate import is activated. Finally, this pyruvate 
generation flux is directed toward branched-chain amino acids, 
particularly valine. It should be noted, however, that our ability 
to compare mitochondrial fluxes of the mutant strain in mixed-
carbon medium (sip1Δ in 2% glucose  +  0.2% galactose) in 
particular is limited due to rather wide flux confidence intervals 
resulting from the 13C FVA (García Martín et al., 2015). The best 
fit values, nonetheless, are consistent with these trends.
3.7. aspartate/Threonine Biosynthesis
In the absence of galactose, both strains appear to direct pyruvate 
flux mainly toward ethanol and aspartate/threonine biosynthesis. 
The split of pyruvate carboxylase flux toward aspartate/threonine 
biosynthesis and production of cytosolic malate is displayed in 
Figure 6 for all strain/condition pairs and individual flux values 
and their absolute ranges from the ELVA are presented in Table 5. 
Deletion of SIP1 in glucose-repressing conditions (base in 2% 
glucose vs sip1Δ in 2% glucose) resulted in a ~35% decrease 
in pyruvate carboxylase and a ~41% decrease in flux toward 
aspartate/threonine biosynthesis. The presence of 0.2% galactose 
in the medium of the base strain (base in 2% glucose vs base in 
2% glucose +  0.2% galactose) resulted in a ~10% increase in 
pyruvate carboxylase activity and a ~80% decrease in flux toward 
aspartate/threonine biosynthesis. Similarly, adding galactose to 
the medium of the sip1Δ mutant (sip1Δ in 2% glucose vs sip1Δ 
in 2% glucose + 0.2% galactose) resulted in a ~32% increase in 
pyruvate carboxylase flux and a ~66% decrease in flow toward 
aspartate/threonine biosynthesis. As before, the flux confidence 
intervals for SG are quite wide, limiting the quality of the infer-
ences for this particular strain/condition.
4. DiscUssiOn
We previously (Shymansky, 2011) observed an increase in 
maximum specific growth rate upon deletion of SIP1 in medium 
containing both glucose and galactose in a background similar to 
this study (S288c ura3Δ gal1Δ). This increase was unreported in 
the literature and, thus, attracted our attention for further investi-
gation. We chose to perform an exploratory analysis of this unre-
ported phenotype from a fluxomic perspective in a similar set of 
base and sip1Δ mutant strains constructed in a CEN.PK113-7D 
ura3Δ gal1Δ background. Exponential-phase intracellular flux 
profiles were inferred from 13C tracer experiments using 2S-13C 
MFA for all four strain/condition pairs and compared. Our hope 
was to compare the redistribution of fluxes, if any, resulting from 
deletion of SIP1 and/or inclusion of galactose in glucose medium 
and identify any resulting patterns.
A number of unexpected phenotypic differences were encoun-
tered during these investigations. Glucose repression appeared 
to be lessened at the 1/10 galactose-to-glucose ratio used. Under 
glucose-repressing conditions, the cell is expected to ignore other 
substrates. However, here, we find that the presence of galactose 
for the base strain results in an unpublished increase in growth 
rate (Table 4; Figure 3) and redistribution of flux from the PPP to 
the mitochondria and subsequent valine production. More spe-
cifically, this additional sugar resulted in decreased flux through 
the PPP and increased flow through mitochondrial pyruvate, via 
import of pyruvate and NADP-dependent malic enzyme, with 
subsequent cytosolic production of valine (see Figures S9–S12 
in Supplementary Material). Additionally, switching the sip1Δ 
FigUre 5 | split of flux between glycolysis and the PPP for all strain/condition pairs. Strain/condition pair designations U, S, UG, and SG refer to base in 
2% glucose (a), sip1Δ in 2% glucose (B), base in 2% glucose + 0.2% galactose (c), and sip1Δ in 2% glucose + 0.2% galactose (D), respectively. Flux values and 
their absolute ranges obtained from the ELVA are presented in Table 5. PPP flux decreases markedly for both the base and sip1Δ mutant when in the presence of 
galactose (U vs UG and S vs SG) in spite of the glucose-repressing conditions. The size of the arrow corresponds to the reaction flux. Names in red are reaction 
names used according to the BIGG data base (King et al., 2015). The middle value for each red reaction label is the flux value corresponding to best fit to measured 
data; the left and right values below are the minimum and maximum values of the flux compatible with the labeling data (from the 13C FVA). For a description of 
colorful cofactor arrows, see the Fits and ELVA plots subsection in the Results section. Flux maps for the other reactions can be found in the Supplementary Material.
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mutant from glucose-only to mixed glucose/galactose medium 
resulted in a similar increase in maximum specific growth rate 
and decrease in PPP flux.
The most striking implication of these results is that glucose 
repression in mixed glucose/galactose medium is not as strict as 
we anticipated, at least not in a galΔ background. We find this 
TaBle 5 | Flux values corresponding to the split between glycolysis and the PPP, visualized in Figure 5, and that between cytosolic aspartate and 
malate synthesis, visualized in Figure 6.
glycolysis/PPP split aspartate/malate split
strain/condition heX1 g6PDh2 Pgi Pc asPTa MDh
U 1.00 0.41 (0.40/0.48) 0.58 (0.51/0.60) 0.43 (0.38/0.51) −0.42 (−0.48/−0.37) 0.00 (−0.01/0.01)
S 1.00 0.12 (0.11/0.13) 0.87 (0.75/0.9) 0.28 (0.27/0.35) −0.25 (−0.32/−0.24) 0.00 (−0.05/0.02)
UG 1.00 0.03 (0.02/0.03) 0.96 (0.87/1.0) 0.47 (0.39/0.47) −0.09 (−0.11/−0.09) −0.36 (−0.46/−0.27)
SG 1.00 0.01 (0.00/0.02) 0.98 (0.92/1.3) 0.37 (0.02/0.60) −0.08 (−0.18/−0.01) −0.28 (−0.52/0.02)
Strain/condition pair designations U, S, UG, and SG refer to base in 2% glucose, sip1Δ in 2% glucose, base in 2% glucose + 0.2% galactose, and sip1Δ in 2% glucose + 0.2% 
galactose, respectively. HEX1, G6PDH2, and PGI refer to the hexokinase, glucose 6-phosphate dehydrogenase, and glucose-6-phosphate isomerase reactions, respectively. PC, 
ASPTA, and MDH refer to the pyruvate carboxylase, aspartate transaminase, and malate dehydrogenase reactions, respectively. Flux values and their minimum and maximum values 
obtained from the ELVA are provided. All fluxes are unitless and normalized to the glucose consumption rate.
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apparent violation of glucose repression plausible based on a 
recent reevaluation of this phenomenon. There are instances in 
the literature of galactose regulation (Escalante-Chong et al., 2015; 
Venturelli et al., 2015; Wang et al., 2015), activating while glucose 
is being actively consumed, even without the loss of galactose 
metabolism via knockout of GAL1. Escalante-Chong et al. (2015) 
demonstrated the existence of a ratio-sensing mechanism using, 
among other efforts, a series of microwell experiments where they 
monitored the expression of yellow fluorescent protein (YFP) 
under a GAL1 promoter over a range of galactose-to-glucose 
ratios in an S288c background. They determined that the range 
of galactose-to-glucose ratios was barely explored in the literature 
and that YFP was expressed past a particular galactose/glucose 
concentration ratio. The beginning of this expression activation 
happened to occur at the same 1/10 ratio of galactose-to-glucose 
used in this study. Although their strain background was S288c 
(compared to CEN.PK113-7D in this study) and they moni-
tored growth in microwell plates (instead of shake flasks), it is 
possible that a similar effect might be occurring, even if CEN.
PK113-7D is known to exhibit phenotypic differences relative to 
S288c (Nijkamp et al., 2012). More specifically, it is possible that 
galactose is entering the cell due to this ratio-sensing mechanism 
and indirectly influencing the growth rate. The galactose cannot 
contribute material directly to cellular mass nor to that flowing 
through the metabolic network due to the GAL1 knockout. We 
speculate that the accompanying flux redistribution represents 
some sort of sensing of and preparation for degradation of 
galactose, a phenomenon that has been previously reported for 
S. cerevisiae (New et al., 2014; Venturelli et al., 2015; Wang et al., 
2015).
We found deletion of SIP1 to have important effects on 
glucose-repressed metabolism. SIP1 appears to be an obligatory 
footnote in yeast glucose repression literature. If mentioned at all, 
it is mostly described as the β-subunit of the Snf1 kinase complex. 
Sometimes details about its localization or role in sequestering 
the complex in the vacuole are mentioned but it appears to be 
largely ignored. We suspect this is due to the lack of a growth 
phenotype accompanying knockout of SIP1. To our knowledge, 
this and our previous work (Shymansky, 2011) are the only stud-
ies to even attempt to infer fluxes in a SIP1 null mutant and to 
report extracellular exchange rates other than for glucose. We 
were surprised to find that, despite no difference in growth rate 
between both strains, deletion of SIP1 in glucose-only medium 
appeared to effectively decrease absolute extracellular ethanol 
and glucose exchange rates and decrease flow toward aspartate 
and threonine biosynthesis. The same trends were either not 
observed in mixed glucose/galactose medium or the confidence 
intervals of these patterns were too wide to definitively note dif-
ferences. These differences resulting from deletion of SIP1 are in 
contrast to a previous study (Zhang et al., 2010) that noted no 
differences in ethanol yield, growth rate, nor glucose exchange 
rate upon knockout of SIP1. However, both strains in our study 
were Gal1− while the 2010 Zhang et al. strains had intact GAL1 
genes.
Our results are consistent with our mechanistic understanding 
that Sip1 is a negative regulator of the GAL system. Deletion of SIP1 
appears to amplify the effect galactose has on growth rate. Why 
deletion of SIP1 would decrease glucose consumption, ethanol 
excretion, and aspartate/threonine biosynthesis rates is unclear, 
though it appears the cell is diverting additional resources toward 
maintaining its growth rate. Additionally, it appears that galactose 
needed to be present to see an increase in maximum specific 
growth rate from deletion of SIP1. Aside from the differences 
noted above, normal patterns of glucose repression (e.g., ethanol 
fermentation and repression of TCA and glyoxylate cycle activity) 
appeared in all four strain/condition pairs. Unfortunately, our 
flux confidence intervals are too wide to meaningfully compare 
the flux profile of the sip1Δ mutant, other than the PPP patterns, 
in mixed glucose/galactose medium with the remaining three 
strain/condition pairs. Thus, our analysis regarding it is limited 
to its higher growth rate and this section of the network. While 
this may seem like a disadvantage, it highlights a strength of our 
analysis. The combination of the ELVA and 13C FVA allows us to 
judge the consistency of our model, data, inferred flux profiles, 
and simulated labeling and when it is or is not appropriate to 
derive further conclusions.
In this study, we have shown how to go from gross phenotypic 
changes (e.g., growth rate, glucose, and ethanol input changes) 
to mechanistic metabolic insights by using modeling techniques 
based on constraining comprehensive genome-scale models by 
13C labeling data. In particular, the use of the 2-scale version of 13C 
MFA, notably expanding the core set of reactions until acceptable 
simulated labeling ranges were obtained, led to our insights in 
mitochondrial transport. Most 13C MFA studies do not include 
these mitochondrial transport reactions. In fact, the initial carbon 
transition model in this study did not include them. It was only 
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through the process of adding them to tighten the computational 
error in the ELVA plots and then visualizing the fluxes that it 
became apparent that this cycle was occurring.
To our knowledge, this is the first published study to 
investigate the relative effects of the presence of galactose and 
knockout of SIP1 in normally carbon repressing conditions from 
a fluxomic perspective. We also encountered increases in growth 
rate when galactose was present in normally glucose-repressing 
medium not found in the scientific literature. It is also one of the 
first to apply 2S-13C MFA to model yeast. This model (as every 
modeling endeavor) needs to rely on a variety of assumptions 
(e.g., steady state conditions, completeness of the genome-scale 
stoichiometry, cell homogeneity, lack of flux flow from metabolic 
periphery to core reactions, no accumulation of intermediate 
metabolites, etc.). Some of the assumptions the model is based 
on may fail, so it is advisable that these insights be confirmed 
through further experiments (e.g., labeling measurements for 
additional metabolites or proteomics/transcriptomics studies). 
FigUre 6 | split of pyruvate carboxylase flux split for all strain/condition pairs. Strain/condition pair designations U, S, UG, and SG refer to base in 2% 
glucose (a), sip1Δ in 2% glucose (B), base in 2% glucose + 0.2% galactose (c), and sip1Δ in 2% glucose + 0.2% galactose (D), respectively. Flux values and their 
absolute ranges obtained from the ELVA are presented in Table 5. Pyruvate carboxylase flux splits between aspartic acid biosynthesis and generation of cytosolic 
malate. Deletion of SIP1 in glucose-repressing conditions (U vs S and UG vs SG) resulted in decreased pyruvate carboxylase (PC) and aspartate/threonine 
biosynthesis (ASPTA). Adding galactose to the medium decreased aspartate/threonine biosynthesis for both U and S. See previous figure for diagram explanation. 
For a description of colorful cofactor arrows, see the Fits and ELVA plots subsection in the Results section. Flux maps for the full model can be found in the 
Supplementary Material.
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Intracellular metabolite labeling distribution SD input for base in 2% glucose + 
0.2% galactose. Table s8. Intracellular metabolite labeling distribution input 
for sip1∆ in 2% glucose + 0.2% galactose. Table s9. Intracellular metabolite 
labeling distribution SD input for sip1∆ in 2% glucose + 0.2% galactose.  
Figure s1. Detailed measured/simulated MDV fits for sip1∆ in 2% glucose. 
Figure s2. Detailed measured/simulated MDV fits for base in 2% glucose + 
0.2% galactose. Figure s3. Detailed measured/simulated MDV fits for sip1∆ in 
2% glucose + 0.2% galactose. Figure s4. ELVA plots for all four strain/condition 
pairs. Figure s5. Flux profile corresponding to base in 2% glucose. Figure s6. 
Flux profile corresponding to sip1∆ in 2% glucose. Figure s7. Flux profile 
corresponding to base in 2% glucose + 0.2% galactose. Figure s8. Flux profile 
corresponding to sip1∆ in 2% glucose + 0.2% galactose. Figure s9. Zoomed 
in section of flux map corresponding to mitochondrial import of pyruvate/malate 
and production of branched-chain amino acids for base in 2% glucose.  
Figure s10. Zoomed in section of flux map corresponding to mitochondrial 
import of pyruvate/malate and production of branched-chain amino acids for 
sip1∆ in 2% glucose. Figure s11. Zoomed in section of flux map corresponding 
to mitochondrial import of pyruvate/malate and production of branched-chain 
amino acids for base in 2% glucose + 0.2% galactose. Figure s12. Zoomed in 
section of flux map corresponding to mitochondrial import of pyruvate/malate 
and production of branched-chain amino acids for sip1∆ in 2% glucose + 0.2% 
galactose.
aDDiTiOnal File 2 | Jupyter notebook QMM library 2s-13c MFa 
calculation code and input files. Zip file containing a Jupyter notebook file 
(two_scale_sip1_calculations.ipynb) used to run all flux calculations, another 
Jupyter notebook (extracellular_flux_calculation_example.ipynb) demonstrating 
the an example extracellular flux calculation, the QMM library code necessary 
to infer flux profiles via 2S-13C MFA, text file inputs for the glucose feed labeling, 
extracellular fluxes, measured intracellular metabolite MDVs, the standard 
deviations corresponding to these measured MDVS, genome-scale model, and 
the core reaction network files corresponding to strain/condition pairs U, S, UG, 
and SG.
aDDiTiOnal File 3 | example extracellular flux calculation and 
derivation of formula. This is the.html file corresponding to the Jupyter 
notebook found in Additional file 2 that demonstrates the derivation of the formula 
used to calculate extracellular fluxes and an example of its use.
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